Damien Vaccines

Damien Vaccines is a biotechnology company focused on the development of next-generation vaccines for neglected tropical diseases and global infectious threats, specifically tuberculosis and leprosy. The company leverages advanced recombinant protein technology and novel adjuvant systems to enhance immune responses in populations where traditional vaccines have shown limited efficacy. Damien Vaccines aims to address the significant global health burden of mycobacterial infections through targeted research and development. Their work is often characterized by a commitment to providing accessible and effective immunization solutions for underserved regions.